Atomoxetine
| Atomoxetine | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 255.35 g/mol [1] |
| Melting point | 161-165 ºC [1] |
| Boiling point | 64-65 ºC at 0.760 mmHg [1] |
| Solubility | White to practically white solid ... solubility of 27.8 mg/L in water. /Hydrochloride/ [1] |
| Predicted LogP | 3.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H21NO [1] |
| IUPAC name | (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine [1] |
| SMILES | CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2 [1] |
| InChI | InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1 [1] |
| InChIKey | VHGCDTVCOLNTBX-QGZVFWFLSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 4.5 – 25 hours |
| Dosing[] |
|---|
| Oral [] | |
|---|---|
| Light | ≤ 25 mg(8x - 66.7%) |
| Common | 25 mg |
| Strong | 25 - 50 mg(4x - 33.3%) |
| Heavy | 50 mg |
| Extreme | 50 mg + |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Atomoxetine (also known as Atomoxetine, Tomoxetine, Tomoxetina, Tomoxetinum, Atomoxetina, methyl[(3R)-3-(2-methylphenoxy)-3-phenylpropyl]amine, Dtxsid9044297, Benzenepropanamine, N-methyl-γ-(2-methylphenoxy)-, (γR)-, Chebi:127342 or Ad313 component atomoxetine) is a
Chemistry
Stereochemistry []
Atomoxetine is a achiral mixture.
Pharmacology
ATC Classification
In the nervous system (N) atomoxetine acts as a stimulant (N06B), sympathomimetic (N06BA), atomoxetine (N06BA09) and psychoanaleptic (N06).[1]Metabolism
Subjective effects []
| Pilz / Atomoxetine [] | |
|---|---|
Routes:
| |
Legal status []
- Australia: Atomoxetine is a S4 substance.
- Brazil: Atomoxetine is a C1 substance.[2]
- Canada: Atomoxetine is a prescription only substance.
- New Zealand: Atomoxetine is a Prescription only substance.
- United Kingdom: Atomoxetine is a prescription only substance.
- United States: Atomoxetine is a prescription only substance.
- European Union: Atomoxetine is a prescription only substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 54841, Atomoxetine. Accessed April 11, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/54841
Anvisa. RDC Nº 816 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. September 15, 2023. Accessed April 11, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-816-de-15-de-setembro-de-2023-510390164